Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Applied Health Economics and Health Policy
|
October 27, 2016
Achieving and Sustaining Universal Health Coverage: Fiscal Reform of the National Health Insurance in Taiwan
Jesse Yu-Chen Lan
Journal of Pharmaceutical Sciences
|
August 14, 2020
Controlled Solvent Removal from Antiviral Drugs and Excipients in Solution Enables the Formation of Novel Combination Multi-Drug-Motifs in Pharmaceutical Powders Composed of Lopinavir, Ritonavir and Tenofovir
Jesse Yu, Danni Yu, Sarah Lane, et al.
Frontiers in Psychology
|
December 5, 2022
Teachers' attitudes to cultural diversity: Results from a qualitative study in Russia and Taiwan
Jui-Sheng Wang, Jesse Yu-Chen Lan, Rezeda R Khairutdinova, et al.
International Journal of Surgery Case Reports
|
April 28, 2024
Total pancreatectomy in a patient with a dermadrome caused by intraductal papillary mucinous neoplasm: A case report
Masashi Kuno, Katsutoshi Murase, Masahiro Fukada, et al.
Cancers
|
August 29, 2024
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression
Jesse Yu, Xiaolin Xu, James Ian Griffin, et al.
Pharmacology & Therapeutics
|
January 9, 2022
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
Jesse Yu, Qingxin Mu, Millie Fung, et al.
Current Cancer Drug Targets
|
October 19, 2018
Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies
Junjie Zou, Juanfang Lin, Chao Li, et al.
Pharmaceutics
|
January 21, 2022
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models
Linxi Zhu, Qingxin Mu, Jesse Yu, et al.
Biopharmaceutics & Drug Disposition
|
May 10, 2023
Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds
Jialin Mao, Fang Ma, Jesse Yu, et al.
Nanomedicine (London, England)
|
February 20, 2016
Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS
Jingwei Shao, John C Kraft, Bowen Li, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Applied Health Economics and Health Policy
|
October 27, 2016
Achieving and Sustaining Universal Health Coverage: Fiscal Reform of the National Health Insurance in Taiwan
Jesse Yu-Chen Lan
Journal of Pharmaceutical Sciences
|
August 14, 2020
Controlled Solvent Removal from Antiviral Drugs and Excipients in Solution Enables the Formation of Novel Combination Multi-Drug-Motifs in Pharmaceutical Powders Composed of Lopinavir, Ritonavir and Tenofovir
Jesse Yu, Danni Yu, Sarah Lane, et al.
Frontiers in Psychology
|
December 5, 2022
Teachers' attitudes to cultural diversity: Results from a qualitative study in Russia and Taiwan
Jui-Sheng Wang, Jesse Yu-Chen Lan, Rezeda R Khairutdinova, et al.
International Journal of Surgery Case Reports
|
April 28, 2024
Total pancreatectomy in a patient with a dermadrome caused by intraductal papillary mucinous neoplasm: A case report
Masashi Kuno, Katsutoshi Murase, Masahiro Fukada, et al.
Cancers
|
August 29, 2024
Drug Combination Nanoparticles Containing Gemcitabine and Paclitaxel Enable Orthotopic 4T1 Breast Tumor Regression
Jesse Yu, Xiaolin Xu, James Ian Griffin, et al.
Pharmacology & Therapeutics
|
January 9, 2022
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
Jesse Yu, Qingxin Mu, Millie Fung, et al.
Current Cancer Drug Targets
|
October 19, 2018
Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies
Junjie Zou, Juanfang Lin, Chao Li, et al.
Pharmaceutics
|
January 21, 2022
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models
Linxi Zhu, Qingxin Mu, Jesse Yu, et al.
Biopharmaceutics & Drug Disposition
|
May 10, 2023
Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds
Jialin Mao, Fang Ma, Jesse Yu, et al.
Nanomedicine (London, England)
|
February 20, 2016
Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS
Jingwei Shao, John C Kraft, Bowen Li, et al.
Page
of 6